Hikal Ltd share price logo

Hikal Ltd (HIKAL)

₹297.451.9%

bell
Get free price alerts. Set up your Free investment account to get Live Prices. >
Overview
Fundamentals
Q3 '23 Results
Technicals
News and Events

Hikal Ltd share Performance

  • ₹296.1
    ₹305.4
    ₹297.45
    downward going graph

    0.45%

    Low

    Day's Volatility:3.13%

    High

    2.67%

    downward going graph
  • ₹250.1
    ₹331.2
    ₹297.45
    downward going graph

    15.92%

    Low

    52 Weeks Volatility:27.27%

    High

    11.35%

    downward going graph
1 Month Return2.64 %
3 Month Return2.43 %
1 Year Return-1.08 %
Previous Close₹303.20
Open₹303.20
Volume2.44L
Upper Circuit-
Lower Circuit-
Market Cap₹3,738.48Cr

Analyst Rating

based on 1 analysts

BUY
100.00%
Buy
0.00%
Hold
0.00%
Sell

Based on 1 analysts offering long term price targets for Hikal Ltd. An average target of ₹330

Source: S&P Global Market Intelligence

Company Information

Hikal Limited is an Indian-based company, incorporated in 1988, with global recognition in the pharmaceutical, crop protection, animal health, biocides and specialty chemicals industries. It has 5 manufacturing facilities in 3 states, producing various chemical intermediates, active pharma ingredients, APIs and contract research activities. With their multiple partnerships and technological expansion projects, they have achieved milestones such as receiving the 5 Star Safety Award from the UK British Safety Council and their promotion to a trading house status. They have acquired an agrochemical manufacturing site from Novartis India Limited, which was followed by an investment in a JV with a Sinochem Corporation China subsidiary. Furthermore, they provide human and animal health products, amongst others. Recent developments such as the long-term contracts with life science companies, the sale of the RD unit and the bonus share issuance to shareholders indicate the company's success.

Share Price: ₹297.45 per share as on 03 May, 2024 04:01 PM
Market Capitalisation: ₹3,738.48Cr as of today
Revenue: ₹438.54Cr as on December 2023 (Q4 23)
Net Profit: ₹16.14Cr as on December 2023 (Q4 23)
Listing date: 14 Feb, 2001
Chairperson Name: Jai Hiremath
OrganisationHikal Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Hikal Ltd

  • Anand Rathi Recommends Buying Hikal with Target Price of Rs. 390 - 18 Apr, 2024

    Anand Rathi recommends initiating long positions in Hikal within the range of 285-310, with a target price of Rs. 390. The stock has established strong support levels and broken above a bearish trendline, signaling bullish momentum in the short to medium term.

  • Hikal Ltd Stock Soars Despite Inconsistent Financials - 06 Apr, 2024

    Hikal Ltd's stock increased by 16% over the past week, but the company's fundamentals do not give a clear sign about its financial health. Specifically, ROE is studied in this article.

  • ICRA Reaffirms Hikal Ltd's Ratings Despite Dispute - 28 Mar, 2024

    Hikal Limited, a diversified company manufacturing active pharmaceutical ingredients (APIs), has had its ratings reaffirmed by ICRA despite the ongoing dispute between Baba Kalyani and Sugandha Hiremath. The developments have not impacted the company's operations or banking arrangements.

  • Ownership Dispute Over Hikal Ltd Shares - 27 Mar, 2024

    A lawsuit has been filed by Jaidev Hiremath and Sugandha Hiremath against Baba Kalyani, KICL, BFIL, and others over the ownership of 34.01% shares of Hikal Ltd. The Hiremath family is seeking specific performance of obligations cast on BNK pursuant to a family arrangement entered between BNK and his parents.

Fundamentals of Hikal Ltd

Insights on Hikal Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 2.71% to 3.03% in Mar 2024 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 6.13% to 6.55% in Mar 2024 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 6.92 Cr → 16.14 Cr (in ₹), with an average increase of 33.5% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 388.99 Cr → 447.63 Cr (in ₹), with an average increase of 6.7% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Sun Pharmaceuticals Industries Ltd has given 55.2% return, outperforming this stock by 56.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 134.2% return, outperforming this stock by 130.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 68.85% of holdings in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 21.86% to 21.07% in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, HIKAL stock has moved down by -1.1%

Hikal Ltd Valuation

Hikal Ltd in the last 5 years

  • Overview

  • Trends

Lowest (8.33x)

March 24, 2020

Today (51.20x)

May 3, 2024

Industry (62.63x)

May 3, 2024

Highest (81.58x)

January 3, 2023

LowHigh

Mutual Fund Holdings

Funds Holdings
Tata Small Cap Fund Direct GrowthTata Small Cap Fund Direct Growth1.4%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct GrowthICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth0.29%
Motilal Oswal Nifty Microcap 250 Index Fund Direct GrowthMotilal Oswal Nifty Microcap 250 Index Fund Direct Growth0.18%
Groww Nifty Total Market Index Fund Direct GrowthGroww Nifty Total Market Index Fund Direct Growth0.01%

Shareholding Pattern

InvestorsHoldings %Prev. 1 periods3M change
Promoter Holdings
68.85%
0.00
Foreign Institutions
6.55%
0.00
Mutual Funds
3.03%
0.00
Retail Investors
21.07%
0.00
Others
0.5%
0.00

Technicals of Hikal Ltd share

News & Events of Hikal Ltd

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Hikal Ltd shares.

Hikal Ltd (HIKAL) share price today is ₹297.45

Hikal Ltd is listed on NSE

Hikal Ltd is listed on BSE

  • Today’s highest price of Hikal Ltd is ₹305.4.
  • Today’s lowest price of Hikal Ltd is ₹296.1.

PE Ratio of Hikal Ltd is 51.2

PE ratio = Hikal Ltd Market price per share / Hikal Ltd Earnings per share

Today’s traded volume of Hikal Ltd(HIKAL) is 2.44L.

Today’s market capitalisation of Hikal Ltd(HIKAL) is ₹3738.48Cr.

Hikal Ltd(HIKALPrice
52 Week High
₹331.2
52 Week Low
₹250.1

Hikal Ltd(HIKAL) share price is ₹297.45. It is down -10.19% from its 52 Week High price of ₹331.2

Hikal Ltd(HIKAL) share price is ₹297.45. It is up 18.93% from its 52 Week Low price of ₹250.1

Hikal Ltd(HIKALReturns
1 Day Returns
-5.75%
1 Month Returns
2.64%
3 Month Returns
2.43%
1 Year Returns
-1.08%